Company intelligence / Profile preview

Cankado

Ownership: Private
Development stage: Other

Overview

Cankado offers a digital health solution that enables the analysis and tracking of symptoms in oncology patients, aiming to improve patient safety and quality of life during cancer treatment. The company’s technology supports self-care and remote monitoring but does not itself conduct clinical trials for therapeutics.

Therapeutic areas: Oncology
Modalities: DeviceDigital health platform (for symptom tracking and patient management)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Cankado.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cankado.

Explore the full profile